Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.305NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.50NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
unclassifiableNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KS.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCENSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HN.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GU.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.6.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.12.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LZ.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KW.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KU.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.4.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LP.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LF.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LQ.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LY.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MD.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LZ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MB.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.10.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EF.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EK.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.6.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.23.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.64NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.68NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.65 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FW.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HN.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.1.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BS.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.75.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used